#Takeda

1 article

Alex Dudov Alex Dudov Industry
8 months ago

Takeda's AI-Discovered Psoriasis Drug Hits 50% PASI 90 in Phase 3 Trial

Takeda reports positive Phase 3 results for zasocitinib, an AI-assisted oral TYK2 inhibitor for psoriasis, with 50% of patients achieving near-complete skin clearance by Week 16.

Posts feed
Anthropic Opens MHS Preview to Connect AI Agents With Physical Hardware
14 hours ago
OpenAI's $122 Billion Superapp Strategy Signals a Major AI Platform Shift
4 months ago
BitVLA Shrinks Robot AI by 11x While Boosting Speed 4.4x
4 months ago
LFM2.5-350M Debuts With Strong Benchmark Results Across 6 Evaluation Suites
4 months ago
Grok 4.20 Multi-Agent Beta Ranks #7 in Search Arena Leaderboard
4 months ago
Claude Code Leak Reveals 4 Key Features Powering Autonomous AI Systems
4 months ago
RISE Robot Framework Boosts Task Success Rates by 35% Using AI-Driven Imagination
4 months ago
Multi-Agent AI Systems Face 15 Emerging Social Risks, New Study Finds
4 months ago
Mistral AI Raises $830M to Build Paris AI Data Center
4 months ago
OpenAI Codex Adds Claude Code CLI Integration in Cross-Platform Move
4 months ago
Follow us on Twitter

Aigazine is an independent publication covering artificial intelligence — new models, research, the companies building them, and the industries they reshape. Published from Tbilisi, Georgia (0179, Tbilisi City, Vake District, 49 Besarion Zhghenti Street, VAT 305786600).

© 2026 Aigazine

We use cookies to improve your experience on our site and to show you relevant advertising. To find our more, read our privacy policy and cookie policy